Circulating Nanotraces to Identify the Cause of Stroke

Circulating Nanotraces to Identify the Cause of Stroke - CINTICS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON52758

Enrollment

750

Registered

2020-09-11

Start date

2020-10-16

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular accident stroke

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 18 years or older - Presenting with symptoms suggestive of stroke - Written informed consent (deferred)

Exclusion criteria

Exclusion criteria: Untreated coagulation abnormalities Specific stroke treatment has started before study blood has been collected

Design outcomes

Primary

Measure	Time frame
The collected blood will be analysed on the presence of differentiating markers, in this case EV concentrations, that can be related to different causes of stroke. It will be examined whether ischemic strokes can be differentiated from hemorrhagic strokes and stroke mimics. Moreover, in the ischemic stroke group it will be examined whether small vessel occlusions can be discriminated from large-vessel occlusions.	—

Measure

Time frame

The collected blood will be analysed on the presence of differentiating markers, in this case EV concentrations, that can be related to different causes of stroke. It will be examined whether ischemic strokes can be differentiated from hemorrhagic strokes and stroke mimics. Moreover, in the ischemic stroke group it will be examined whether small vessel occlusions can be discriminated from large-vessel occlusions.

—

Secondary

Measure	Time frame
Secondary, relations between the EV concentration(s) and other clinical and radiological findings than the diagnosis will be explored.	—

Countries

Netherlands

Outcome results